Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 ZURICH, March 19, 2026--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage ...
Iran did not rebuild its uranium enrichment capability following joint U.S.-Israeli strikes against its nuclear program last year, U.S. Director of National Intelligence (DNI) Tulsi Gabbard told a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results